Zimmer Biomet Holdings, Inc.

ZBH Healthcare Medical Devices

Zimmer Biomet Holdings, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $8.2 billion, up 7.20% from fiscal 2024.

Revenue
+3.07%
EPS
−13.5%
Free cash flow
+29.8%
Total debt
−7.50%

Quarter to September 2026, against a year earlier

105.28 1.57 −1.47%
Market cap
$20.4B
P/E
26.9×
Fwd P/E
18.9×
Dividend yield
0.90%
F-score
6/9
Altman Z
2.38
Beneish M
−2.59
Dividend safety
72/100
Older periods Dec '25 Mar '26 Jun '26 Sep '26
P/E ratio

+8 more quarters

25.19 23.36 20.85 22.36
P/S ratio
2.16 2.10 1.94 1.97
P/FCF ratio
16.53 17.49 15.96 15.16
P/Operating CF
34.41 49.06 36.95 30.22
P/B ratio
1.40 1.39 1.31 1.34
EV/Sales
3.00 2.93 2.78 2.80
EV/EBITDA
11.28 10.78 10.21 10.59
EV/FCF
22.96 24.48 22.78 21.53
Current Ratio
1.98 1.73 1.69 1.46
Net Debt/EBITDA
15.80 10.96 11.84 0.00
Debt/Equity
0.59 0.59 0.59 0.59
Earnings Yield
3.97% 4.28% 4.80% 4.47%
Free Cash Flow Yield
6.05% 5.72% 6.26% 6.60%
Free Cash Flow per Share
1.60 1.06 1.28 1.82
Book value per Share
64.17 65.03 65.73 66.80
Free Cash Flow
315.90 206.90 246.00 347.40
EV/EBIT
22.52 20.93 19.60 20.69
Other line items

Show all line items

Columns are period end dates · fundamentals updated 5 Nov 2026